lnterleukin-6 (IL-6) and/or Soluble IL-6 Receptor Down-regulation of Human Type II Collagen Gene Expression in Articular Chondrocytes Requires a Decrease of Sp1·Sp3 Ratio and of the Binding Activity of Both Factors to the COL2A1 Promoter.

MLA

Porée, Benoit, et al. “Lnterleukin-6 (IL-6) and/or Soluble IL-6 Receptor Down-Regulation of Human Type II Collagen Gene Expression in Articular Chondrocytes Requires a Decrease of Sp1·Sp3 Ratio and of the Binding Activity of Both Factors to the COL2A1 Promoter.” Journal of Biological Chemistry, vol. 283, no. 8, Feb. 2008, pp. 4850–65. EBSCOhost, https://doi.org/10.1074/jbc.M706387200.

APA

Porée, B., Kypriotou, M., Chadjichristos, C., Beauchef, G., Renard, E., Legendre, F., Melin, M., Gueret, S., Hartmann, D., Malléin-Gerin, F., Pujol, J., Boumediene, K., & Galéra, P. (2008). lnterleukin-6 (IL-6) and/or Soluble IL-6 Receptor Down-regulation of Human Type II Collagen Gene Expression in Articular Chondrocytes Requires a Decrease of Sp1·Sp3 Ratio and of the Binding Activity of Both Factors to the COL2A1 Promoter. Journal of Biological Chemistry, 283(8), 4850–4865. https://doi.org/10.1074/jbc.M706387200

Chicago

Porée, Benoit, Magdalini Kypriotou, Christos Chadjichristos, Gallic Beauchef, Emmanuelle Renard, Florence Legendre, Martine Melin, et al. 2008. “Lnterleukin-6 (IL-6) and/or Soluble IL-6 Receptor Down-Regulation of Human Type II Collagen Gene Expression in Articular Chondrocytes Requires a Decrease of Sp1·Sp3 Ratio and of the Binding Activity of Both Factors to the COL2A1 Promoter.” Journal of Biological Chemistry 283 (8): 4850–65. doi:10.1074/jbc.M706387200.